<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04841655</url>
  </required_header>
  <id_info>
    <org_study_id>PI18/01420</org_study_id>
    <nct_id>NCT04841655</nct_id>
  </id_info>
  <brief_title>Tobacco Cessation Among Smokers Under Alcohol and/or Cannabis Treatment</brief_title>
  <acronym>ACT-ATAC</acronym>
  <official_title>Tobacco Cessation Among Smokers Under Alcohol and/or Cannabis Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Català d'Oncologia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Althaia Xarxa Assistencial Universitària de Manresa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Barcelona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Public Health Agency of Barcelona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut Català d'Oncologia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aims: To identify the predictors associated with smoking cessation in smokers under treatment&#xD;
      for alcohol and/or cannabis treated in drug treatment centers (DTC). Methodology: Mixed&#xD;
      methods project with qualitative and quantitative designs (three studies). Study I discussion&#xD;
      groups: of clinical professionals of DTC to explore the barriers/facilitators of these&#xD;
      smokers in quitting and the interventions carried out. Study II Prospective cohort of smokers&#xD;
      in alcohol and/or cannabis treatment that will be followed-up for 12 months. Sample size:&#xD;
      difference in incidence (exposed to cessation interventions versus non-exposed = 12 per 100&#xD;
      years), α = 0.05, β = 0.10, losses = 20% (n = 726). Dependent variables: self-reported and&#xD;
      verified tobacco consumption abstinence, quit attempts, motivation, and self-efficacy.&#xD;
      Independent variables: age, sex, the substance under treatment. Analysis: incidence, relative&#xD;
      risk and simple and multiple logistic regression models (odds ratio and confidence interval,&#xD;
      CI, 95%) of quitting. Study III discussion groups: with smokers under alcohol and/or cannabis&#xD;
      treatment selected according to their typology. Analysis: of thematic content and&#xD;
      triangulation qualitative and quantitative results. Expected results: Characterization of&#xD;
      variables that influence tobacco cessation, to improve the design of interventions.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>self-reported and verified tobacco consumption abstinence</measure>
    <time_frame>at twelve months follow-up</time_frame>
    <description>self-reported and verified tobacco consumption abstinence by using CO measurement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Motivation to quit</measure>
    <time_frame>at twelve months follow-up</time_frame>
    <description>self-reported and scored from a Likert scale from 0 to 10 (0= no motivation 10=high motivation)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of cigarettes per day</measure>
    <time_frame>at twelve months follow-up</time_frame>
    <description>self-reported</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stages of Change to quit</measure>
    <time_frame>at twelve months follow-up</time_frame>
    <description>Status of the stages of change to quit according to 5 stages proposed by Prochaska and DiClemente</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1625</enrollment>
  <condition>Mental Health Disorder</condition>
  <condition>Substance Abuse Drug</condition>
  <condition>Alcohol Abuse</condition>
  <condition>Cannabis Use</condition>
  <condition>Tobacco Use</condition>
  <condition>Smoking Cessation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Smokers under treatment for substance abuse (alcohol and/or cannabis) from the province of&#xD;
        Barcelona in Catalonia (Spain)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Smokers (at least 1cig./week)&#xD;
&#xD;
          -  Undertreatment for Cannabis and/or Alcohol Abuse for the first time&#xD;
&#xD;
          -  &gt;=18 years-old&#xD;
&#xD;
          -  Under clinical follow-up&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe cognitive impairment&#xD;
&#xD;
          -  12-month follow-up not guaranteed&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Cristina Martinez Martinez, PhD</last_name>
    <phone>932607335</phone>
    <email>cmartinez@iconcologia.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ariadna Feliu Josa, MPH</last_name>
    <phone>932607357</phone>
    <phone_ext>3076</phone_ext>
    <email>afeliu@iconcologia.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Bellvitge</name>
      <address>
        <city>L'Hospitalet de Llobregat</city>
        <state>Barcelona</state>
        <zip>08908</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Martínez</last_name>
      <phone>932607753</phone>
      <email>cmartinez@iconcologia.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvia Mondon, Dr</last_name>
      <phone>932275400</phone>
      <email>smondon@clinic.cat</email>
    </contact>
    <investigator>
      <last_name>Ariadna Feliu, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pablo Barrio, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>December 9, 2019</study_first_submitted>
  <study_first_submitted_qc>April 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2021</study_first_posted>
  <last_update_submitted>April 8, 2021</last_update_submitted>
  <last_update_submitted_qc>April 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Marijuana Abuse</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
    <mesh_term>Alcoholism</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

